Wolfgang Bernhard1, Christoph Maas2, Anna Shunova2, Michaela Mathes2, Katrin Böckmann2, Christine Bleeker2, Julia Vek2, Christian F Poets2, Erwin Schleicher3, Axel R Franz2,4. 1. Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany. wolfgang.bernhard@med.uni-tuebingen.de. 2. Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany. 3. Department of Internal Medicine IV, Faculty of Medicine, Eberhard-Karls-University, Tübingen, Germany. 4. Center for Pediatric Clinical Studies, Faculty of Medicine, Eberhard-Karls-University, Tübingen, Germany.
Abstract
BACKGROUND: Docosahexaenoic (C22:6) and arachidonic (C20:4) acids are long-chain polyunsaturated fatty acids (LC-PUFA) essential to neonatal development, being present in the glycerophospholipids of all organs, particularly the brain. In plasma, LC-PUFAs are mainly present in lipoprotein lipids, which are neutral lipids (triglycerides and cholesterol esters) and glycerophospholipids, like choline containing phosphatidylcholine (PC). PURPOSE: To guide future supplementation strategies of C22:6 and C20:4 in combination with choline, we determined the distribution of C20:4 and C22:6 between PC and neutral lipid. METHODS: Preterm infant plasma (N = 59, postmenstrual age [PMA] 33.9 wk (32.4-36.0)) and cord plasma (N = 34, PMA 34.0 wk (30.86-38.4)) were investigated. PC and neutral lipids were extracted and analyzed using tandem mass spectrometry and gas chromatography, respectively. Data are reported as medians and 25th/75th percentiles. RESULTS: In cord blood, C20:4-PC and C22:6-PC comprised 36.1% (34.2-38.6) and 10.2% (8.8-12.8) of total PC, respectively. In preterm infant plasma, values were only 20.8% (19.2-23.1) and 5.7% (5.2-6.0), respectively (p < 0.001 each). Nevertheless, in preterm infant plasma, 80.6% (77.6-83.0) of C20:4 and 86.0% (83.0-88.9) of C22:6 were found in PC. These values exceeded the proportions of C20:4 and C22:6 in PC of cord plasma [71.3% (67.8-72.9) and 79.2% (75.2-85.4), respectively] (p < 0.0001 each). CONCLUSION: Irrespective of the low proportions of C20:4-PC and C22:6-PC in preterm infant plasma lipids, PC is the major transporter for C20:4 and C22:6. Our data support the hypotheses that choline deficiency may impair end-organ availability of these LC-PUFA in preterm infants. Therefore, supplementation of C20:4 and C22:6 might better be accompanied by choline supplementation.
BACKGROUND:Docosahexaenoic (C22:6) and arachidonic (C20:4) acids are long-chain polyunsaturated fatty acids (LC-PUFA) essential to neonatal development, being present in the glycerophospholipids of all organs, particularly the brain. In plasma, LC-PUFAs are mainly present in lipoprotein lipids, which are neutral lipids (triglycerides and cholesterol esters) and glycerophospholipids, like choline containing phosphatidylcholine (PC). PURPOSE: To guide future supplementation strategies of C22:6 and C20:4 in combination with choline, we determined the distribution of C20:4 and C22:6 between PC and neutral lipid. METHODS: Preterm infant plasma (N = 59, postmenstrual age [PMA] 33.9 wk (32.4-36.0)) and cord plasma (N = 34, PMA 34.0 wk (30.86-38.4)) were investigated. PC and neutral lipids were extracted and analyzed using tandem mass spectrometry and gas chromatography, respectively. Data are reported as medians and 25th/75th percentiles. RESULTS: In cord blood, C20:4-PC and C22:6-PC comprised 36.1% (34.2-38.6) and 10.2% (8.8-12.8) of total PC, respectively. In preterm infant plasma, values were only 20.8% (19.2-23.1) and 5.7% (5.2-6.0), respectively (p < 0.001 each). Nevertheless, in preterm infant plasma, 80.6% (77.6-83.0) of C20:4 and 86.0% (83.0-88.9) of C22:6 were found in PC. These values exceeded the proportions of C20:4 and C22:6 in PC of cord plasma [71.3% (67.8-72.9) and 79.2% (75.2-85.4), respectively] (p < 0.0001 each). CONCLUSION: Irrespective of the low proportions of C20:4-PC and C22:6-PC in preterm infant plasma lipids, PC is the major transporter for C20:4 and C22:6. Our data support the hypotheses that choline deficiency may impair end-organ availability of these LC-PUFA in preterm infants. Therefore, supplementation of C20:4 and C22:6 might better be accompanied by choline supplementation.
Authors: Kerry-Ann da Costa; Olga G Kozyreva; Jiannan Song; Joseph A Galanko; Leslie M Fischer; Steven H Zeisel Journal: FASEB J Date: 2006-07 Impact factor: 5.191
Authors: Wolfgang Bernhard; Marco Raith; Rebecca Kunze; Vera Koch; Martin Heni; Christoph Maas; Harald Abele; Christian F Poets; Axel R Franz Journal: Eur J Nutr Date: 2014-08-23 Impact factor: 5.614
Authors: Leslie M Fischer; Kerry-Ann da Costa; Lester Kwock; Joseph Galanko; Steven H Zeisel Journal: Am J Clin Nutr Date: 2010-09-22 Impact factor: 7.045
Authors: Kerry-Ann da Costa; Karen D Corbin; Mihai D Niculescu; Joseph A Galanko; Steven H Zeisel Journal: FASEB J Date: 2014-03-26 Impact factor: 5.191
Authors: P C Calder; A D Dangour; C Diekman; A Eilander; B Koletzko; G W Meijer; D Mozaffarian; H Niinikoski; S J M Osendarp; P Pietinen; J Schuit; R Uauy Journal: Eur J Clin Nutr Date: 2010-12 Impact factor: 4.016
Authors: Judith Grothe; Joachim Riethmüller; Sandra M Tschürtz; Marco Raith; Chris J Pynn; Dieter Stoll; Wolfgang Bernhard Journal: Cell Physiol Biochem Date: 2015-03-12
Authors: Christopher J Pynn; Neil G Henderson; Howard Clark; Grielof Koster; Wolfgang Bernhard; Anthony D Postle Journal: J Lipid Res Date: 2010-11-10 Impact factor: 5.922
Authors: Wolfgang Bernhard; Anna Full; Jörg Arand; Christoph Maas; Christian F Poets; Axel R Franz Journal: Eur J Nutr Date: 2012-09-09 Impact factor: 5.614
Authors: Ariel B Ganz; Vanessa V Cohen; Camille C Swersky; Julie Stover; Gerardo A Vitiello; Jessica Lovesky; Jasmine C Chuang; Kelsey Shields; Vladislav G Fomin; Yusnier S Lopez; Sanjay Mohan; Anita Ganti; Bradley Carrier; Olga V Malysheva; Marie A Caudill Journal: Int J Mol Sci Date: 2017-01-26 Impact factor: 5.923
Authors: Stephanie S Chassen; Veronique Ferchaud-Roucher; Claire Palmer; Cun Li; Thomas Jansson; Peter W Nathanielsz; Theresa L Powell Journal: J Physiol Date: 2020-05-29 Impact factor: 5.182
Authors: K A Böckmann; A von Stumpff; W Bernhard; A Shunova; M Minarski; B Frische; S Warmann; E Schleicher; C F Poets; A R Franz Journal: Eur J Nutr Date: 2020-05-31 Impact factor: 5.614
Authors: Wolfgang Bernhard; Marco Raith; Anna Shunova; Stephan Lorenz; Katrin Böckmann; Michaela Minarski; Christian F Poets; Axel R Franz Journal: Nutrients Date: 2022-02-08 Impact factor: 5.717